0 NASDAQ Companies - December 2, 2024Trust Stamp to Provide Strategic Update and Announces Annual General Meeting DetailsAtlanta, GA, Dec. 02, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), a global provider of AI-powered technologies, has announced […]Read More
0 NASDAQ Companies - December 2, 2024FAT Brands Foundation Launches Holiday Giving CampaignFAT Brands to Support Charitable Arm’s Initiative with Dollar-for-Dollar Donation Match Up To $50,000 LOS ANGELES, Dec. 02, 2024 (GLOBE […]Read More
0 NASDAQ Companies - December 2, 2024Abacus Life Completes Acquisition of Carlisle Management Company S.C.A.ORLANDO, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) — Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global […]Read More
0 NASDAQ Companies - November 22, 2024VivoPower International PLC Receives Notice from Nasdaq Regarding Compliance with Form 20-F Filing RequirementsDelay in filing form 20F has been due to the significant strategic changes pursuant to a previously announced strategic review […]Read More
0 NASDAQ Companies - November 22, 2024Snail, Inc. to Participate in Noble Capital Markets’ Twentieth Annual Emerging Growth Equity ConferenceCULVER CITY, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or “the Company”), a leading, […]Read More
0 NASDAQ Companies - November 22, 2024Hudson Acquisition I Corp. Announces Signing of Definitive Business Combination Agreement With Aiways Europe, an Electrical Vehicle Company Focused on the Development, Sales and Consumer Solutions Supporting Bevs in the European MarketNew York, NY and Munich, Germany, Nov. 22, 2024 (GLOBE NEWSWIRE) — Hudson Acquisition I Corp. (the “Company” or “HUDA”) […]Read More
0 NASDAQ Companies - November 22, 2024IES Holdings Reports Fiscal 2024 Fourth Quarter and Full Year ResultsHOUSTON, Nov. 22, 2024 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial […]Read More
0 NASDAQ Companies - November 22, 2024Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal MetastasesProspective FORESEE trial of CNSide Cerebrospinal Fluid (CSF) Assay met key primary and secondary endpoints CNSide CSF Assay influenced clinical […]Read More
0 NASDAQ Companies - November 22, 2024Seres Therapeutics to Participate in Piper Sandler Healthcare ConferenceCAMBRIDGE, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) — Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced […]Read More
0 NASDAQ Companies - November 22, 2024AIX Announces Changes to the Board of Directors and Management TeamGUANGZHOU, China, Nov. 22, 2024 (GLOBE NEWSWIRE) — The board of directors (the “Board”) of AIX Inc. (Nasdaq: AIFU) (the […]Read More